Aurora Sheboygan Prices – Daratumumab with Hyaluronidase Injection 1800-30000 Milligrams per 15 Milliliters Subcutaneous Solution is $349.73

Daratumumab with Hyaluronidase injection is a targeted therapy primarily used for treating multiple myeloma, a form of blood cancer affecting plasma cells. This medication is administered as a subcutaneous solution, meaning it is injected under the skin, allowing for faster and more comfortable absorption compared to intravenous methods. The $349.73 fee at Aurora Medical Center Sheboygan County covers a dosage ranging from 1800 to 30000 milligrams per 15 milliliters. This cost typically includes the medication itself and the administration process, but may exclude additional services such as monitoring, supportive medications, or facility fees. To avoid unexpected charges, patients are encouraged to request a detailed, itemized estimate prior to treatment and to confirm insurance coverage specifics.

Cost Breakdown

• Medication: Daratumumab with Hyaluronidase (per unit dosage specified)
• Administration: Subcutaneous injection by healthcare staff
• Included in Fee: The listed price covers both the drug and its administration at the facility
• Possible Exclusions: Additional monitoring, pre-medications, follow-up labs, and facility fees may be billed separately

Associated Costs to Consider

• Pre-treatment laboratory tests (e.g., blood counts, organ function panels)
• Follow-up appointments and monitoring for side effects
• Supportive medications (such as anti-nausea drugs or steroids)
• Possible facility or infusion center charges
• Emergency care in the event of a reaction

Insurance & Payment Advice

• Contact your insurance provider to determine coverage for Daratumumab with Hyaluronidase and related services
• Ask for pre-authorization if required by your insurer
• Request an itemized bill from the facility for transparency
• Inquire about financial assistance or payment plans if you are uninsured or face high out-of-pocket costs

Side Effect Considerations

• Common side effects may include injection site reactions, fatigue, fever, and infections
• Serious reactions such as allergic responses or breathing difficulties may occur and require immediate medical attention
• Regular monitoring is advised to manage and promptly address side effects

Recovery and Patient Tips

• Follow all pre- and post-injection instructions provided by your care team
• Report any side effects or symptoms to your provider promptly
• Arrange for transportation if you feel unwell after the injection
• Stay hydrated and rest as needed after treatment

Frequently Asked Questions

• What is Daratumumab with Hyaluronidase used for?
  This medication is used to treat multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow.
• How is this medication administered?
  Daratumumab with Hyaluronidase is given as a subcutaneous injection, which means it is injected under the skin rather than into a vein.
• Why is Hyaluronidase combined with Daratumumab?
  Hyaluronidase helps the body absorb Daratumumab more efficiently, making the treatment faster and potentially reducing side effects at the injection site.
• Does the $349.73 fee include everything?
  The fee covers the medication and its administration for the specified dosage. Additional services like laboratory tests, monitoring, or other medications may be billed separately.
• Will insurance cover this treatment?
  Coverage depends on your specific insurance plan. It is important to verify benefits, obtain pre-authorization if needed, and confirm what is included in your coverage.
• Are there financial assistance programs available?
  Many facilities and pharmaceutical companies offer financial assistance or payment plans for eligible patients. Ask the billing office or your care team about available resources.
• What side effects should I watch for?
  Common side effects include injection site reactions, fatigue, and mild fever. Report any severe symptoms such as difficulty breathing or signs of an allergic reaction to your healthcare provider immediately.
• How frequent are treatments with Daratumumab with Hyaluronidase?
  The schedule varies based on your treatment plan and response. Your oncologist will provide a personalized schedule.
• What should I do if I miss a scheduled injection?
  Contact your healthcare provider as soon as possible to reschedule and receive instructions on how to proceed.
• Can I get an itemized bill for this service?
  Yes, you have the right to request an itemized bill detailing all charges and services provided.
• Is there any preparation required before receiving the injection?
  Your healthcare team will provide specific instructions, which may include lab tests or pre-medications to reduce the risk of reactions.

Aurora Medical Center Sheboygan County offers a medical service involving the administration of Daratumumab with Hyaluronidase, a subcutaneous solution used primarily in the treatment of multiple myeloma, a type of blood cancer. This medication combines Daratumumab, a monoclonal antibody that targets cancer cells, with Hyaluronidase, an enzyme that aids in the absorption of the drug under the skin. The cost for this service at Aurora Sheboygan is $349.73 for a dosage ranging from 1800 to 30000 milligrams per 15 milliliters, reflecting the center’s pricing for this specific treatment.

What is Daratumumab with Hyaluronidase used for? – Daratumumab with Hyaluronidase is used in the treatment of multiple myeloma, a cancer affecting plasma cells in the bone marrow. How is the medication administered? – It is administered as a subcutaneous injection, meaning it is injected under the skin. Why is Hyaluronidase included in the solution? – Hyaluronidase is included to enhance the absorption of Daratumumab, making the treatment more efficient. What is the cost of this treatment at Aurora Medical Center Sheboygan County? – The cost is $349.73 for a dosage of 1800 to 30000 milligrams per 15 milliliters. Is this treatment covered by insurance? – Coverage can vary, so patients should check with their insurance provider to determine if this specific treatment is covered. Are there any side effects associated with this medication? – Common side effects may include fatigue, nausea, and reactions at the injection site, but patients should consult their healthcare provider for a comprehensive list. How often is this treatment administered? – The frequency of administration depends on the patient’s specific treatment plan, which should be discussed with their healthcare provider. Can this treatment be combined with other therapies? – Yes, it is often used in combination with other cancer treatments, but this should be determined by a healthcare professional.